Unicycive Therapeutics's total assets for Q3 2024 were $38.57M, a decrease of -13.71% from the previous quarter. UNCY total liabilities were $10.72M for the fiscal quarter, a -19.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.